Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein.
S Afr Fam Pract (2004). 2023 May 29;65(1):e1-e6. doi: 10.4102/safp.v65i1.5663.
Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD). The prevalence of CKD among T2DM patients in Africa is 22.0%. The cut-off age for dialysing diabetic patients in the resource-limited state sector in South Africa is 50 years. Type 2 diabetes mellitus patients who develop CKD are likely to be excluded from chronic dialysis and rely on control of risk factors, including blood pressure and blood glucose levels, to prevent CKD progression. We aimed to determine the prevalence of CKD among T2DM patients attending the diabetes clinic at Pelonomi Academic Hospital, Bloemfontein.
In this retrospective cross-sectional study, medical records of patients (January 2016 and December 2018) were reviewed to collect demographic and clinical information.
In total, 244 records were reviewed. Sixty-one (25.0%, 95% confidence interval [CI]: 20% - 30.8%) T2DM patients had CKD. The rate of CKD was slightly higher in males (n = 24/81; 29.6%) compared with females (n = 37/163; 22.7%). Most patients with CKD (n = 58; 95.1%) were 50 years of age. Only 17.8% of patients achieved a glycosylated haemoglobin (HbA1c) of 7.0%. Blood pressure was controlled in 14.3% of hypertensive patients. Renin-angiotensin-aldosterone system inhibitors were used by 78.6% of patients.
A high prevalence of clinically significant CKD among T2DM patients with poor prospects of chronic dialysis in a resource-limited setting was observed. The risk factors for CKD development and progression should be adequately managed in T2DM patients.Contribution: This study emphasises the need for further research and innovation to improve outcomes of T2DM patients with CKD in resource-constrained settings.
2 型糖尿病(T2DM)是慢性肾脏病(CKD)的主要病因。在非洲,T2DM 患者中 CKD 的患病率为 22.0%。在南非资源有限的部门,开始对糖尿病患者进行透析的截止年龄为 50 岁。患有 CKD 的 T2DM 患者可能会被排除在慢性透析之外,只能依靠控制血压和血糖等风险因素来防止 CKD 进展。我们旨在确定比勒陀利亚 Pelonomi 学术医院糖尿病诊所 T2DM 患者的 CKD 患病率。
在这项回顾性横断面研究中,回顾了 2016 年 1 月至 2018 年 12 月期间的患者病历,以收集人口统计学和临床信息。
共审查了 244 份记录。61 例(25.0%,95%置信区间 [CI]:20% - 30.8%)T2DM 患者患有 CKD。与女性(n=163;22.7%)相比,男性(n=81;29.6%)中 CKD 的发生率略高。大多数 CKD 患者(n=58;95.1%)年龄为 50 岁。仅 17.8%的患者糖化血红蛋白(HbA1c)达到 7.0%。在高血压患者中,只有 14.3%的血压得到控制。78.6%的患者使用了肾素-血管紧张素-醛固酮系统抑制剂。
在资源有限的环境中,观察到 T2DM 患者中 CKD 的患病率很高,这些患者进行慢性透析的前景不佳。应在 T2DM 患者中充分管理 CKD 发展和进展的风险因素。
本研究强调需要进一步研究和创新,以改善资源有限环境中 CKD 的 T2DM 患者的结局。